Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

Author： Fernández-Montero José Vicente Vispo Eugenia Anta Lourdes de Mendoza Carmen Soriano Vincent

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.7, 2012-05, pp. : 1007-1014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Assessment of Antiretroviral Drugs Used in the Treatment of Patients with HIV Infection: Focus on Non-Nucleoside Reverse Transcriptase Inhibitors

By Sabbatani S.

Clinical Drug Investigation, Vol. 22, Iss. 4, 2002-01 ,pp. : 253-262

Adis International

Access to resources Recommend Favorite

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

By Buckheit Robert W

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1423-1442

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Development of Next Generation Non-nucleoside Reverse Transcriptase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. : 1045-1057

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S. Dwyer D.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite

Triple nucleoside analogue antiretroviral therapy: expanding the treatment approaches for management of HIV infection

By Moyle G.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1147-1155

Informa Healthcare

Access to resources Recommend Favorite